Rectal cancer Trials in Orange, United States
Conditions / Rectal cancer / Orange, United States
Research into Rectal cancer spans multiple therapeutic approaches and trial phases.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04184973 | Efficacy and Safety of the CG-100 Intraluminal Bypass Device | RECRUITING | NA |
| NCT06205485 | Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer | RECRUITING | — |
| NCT01560377 | Perfusion Assessment in Laparoscopic Left Anterior Resection | COMPLETED | PHASE1 |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT00257322 | Cellular Immune Augmentation in Colon and Rectal Cancer | COMPLETED | PHASE2 |
| NCT02008656 | Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03144765 | Multicenter Phase II Study of Transanal TME (taTME) | ACTIVE_NOT_RECRUITING | — |
| NCT02205307 | A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection | TERMINATED | NA |
| NCT01736072 | RObotic Versus LAparoscopic Resection for Rectal Cancer | COMPLETED | NA |
| NCT00819780 | PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors | COMPLETED | PHASE2 |